Previous close | 206.71 |
Open | 206.84 |
Bid | 206.38 x 1200 |
Ask | 207.15 x 800 |
Day's range | 206.36 - 208.56 |
52-week range | 177.63 - 276.43 |
Volume | |
Avg. volume | 274,806 |
Market cap | 9.736B |
Beta (5Y monthly) | 1.12 |
PE ratio (TTM) | 27.31 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.36 (0.66%) |
Ex-dividend date | 29 Feb 2024 |
1y target est | N/A |
Key Insights Teleflex to hold its Annual General Meeting on 3rd of May Total pay for CEO Liam Kelly includes US$1.06m...
Investing in stocks inevitably means buying into some companies that perform poorly. But the last three years have been...
Teleflex's (TFX) new UroLift 2 System with the ATC platform is designed to treat all prostate types.